YOLFTbeta
Tianjin Chase Sun Pharmaceutical Co Ltd

Tianjin Chase Sun Pharmaceutical Co Ltd

300026 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

3.04CNY-0.07 (-2.25%)

Price History

Full chart

Market Stats

Previous Close3.11
Open3.12
Day Range3.03 – 3.12
52-Week Range2.81 – 3.98
Volume35.75M
Market Cap9.76B
P/E (TTM)325.00
Forward P/E51.02
EPS0.01
Dividend Yield0.31%
Beta0.03
50-Day Avg3.37
200-Day Avg3.42

About

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and sale of various pharmaceutical products in China. The company offers traditional Chinese medicine formula granules; finished drugs, including xuebijing injections, low molecular weight heparin calcium injections, moxifloxacin hydrochloride sodium chloride injections, enoxaparin sodium injections, nadronexacin calcium injections, fasudil hydrochloride injections, ketorheic acid tromethamine injections, ibanoxetine sodium injections, Qingfei Sanjie pills, and Ping Wan anti-cancer pills; raw materials and excipients, such as pharmaceutical excipients, active pharmaceutical ingredients (APIs), and food additives; medical devices, including oxygen concentrators and portable oxygen concentrators; medical and health services; and intelligent supply chain services for pharmaceuticals and medical devices. It also provides chemical reagents, Western patent medicines, enteric casings, heparin sodium, food, beverages, seasonings, tea, candies, and traditional Chinese medicine decoction pieces; pharmaceutical equipment and self-owned housing leasing; pharmaceutical product and medical device research and development; technology consulting, transfer, and promotion; health management, business management, nutritional health, and health information consulting; wholesale and retail of electronic products; import and export of goods and technology; biopharmaceutical project management; project investment; technical service development, transfer, and consulting; consumer electronics and sporting goods sales; computer software and hardware development; general hospital services; nursing services for the elderly and disabled; medical management; diagnosis and treatment; and medical data research activities. The company exports its products to approximately 50 countries and regions. Tianjin Chase Sun Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Tianjin, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wu Jun Lan
  • Employees4.85K
  • HeadquartersBuilding B01, Entrepreneurship Headquarters Base, Tianjin, China, 301700, China
  • Websitehttps://www.chasesun.cn

Leadership

  • Mr. Wu Jun LanVice Chairman & GM · b. 1975
  • Mr. Jiaping DanCFO, Chief Accountant & Non-Independent Director · b. 1981
  • Ms. Yi YangDirector & Secretary · b. 1990
  • Mr. Rui Qiang ChenDeputy General Manager · b. 1977
  • Mr. Kun ZhangDeputy General Manager · b. 1976
  • Mr. Xiao Zhong LuDeputy General Manager · b. 1980

Financials

Income Statement

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue56.22M118.69M187.00M225.08M383.88M561.78M1.23B2.10B2.86B3.35B3.87B3.37B4.22B5.00B6.49B7.67B6.65B6.11B5.78B
Growth (%)-+111.11%+57.55%+20.36%+70.55%+46.34%+118.81%+70.61%+36.54%+16.93%+15.49%-12.75%+25.19%+18.44%+29.69%+18.22%-13.30%-8.14%-5.34%
Cost of Revenue17.02M29.12M44.17M47.28M120.27M175.21M243.69M321.33M469.55M581.23M963.61M937.20M1.25B1.65B2.86B3.27B2.83B2.83B2.79B
Gross Profit39.20M89.57M142.84M177.80M263.61M386.57M985.56M1.78B2.39B2.77B2.90B2.44B2.97B3.35B3.63B4.40B3.82B3.28B2.99B
Gross Margin69.73%75.46%76.38%78.99%68.67%68.81%80.18%84.68%83.60%82.64%75.08%72.22%70.32%67.02%55.95%57.40%57.50%53.73%51.69%
Operating Expense31.50M45.18M63.90M85.60M129.77M217.83M681.98M1.39B1.91B2.19B2.17B1.91B2.68B2.87B2.98B3.53B3.11B2.79B2.95B
Operating Income7.70M44.39M78.94M92.20M133.84M168.74M303.58M386.69M488.49M579.16M733.24M525.27M291.59M483.25M654.11M875.19M712.52M489.27M35.44M
Operating Margin13.69%37.40%42.21%40.96%34.87%30.04%24.70%18.44%17.06%17.30%18.96%15.57%6.90%9.66%10.08%11.41%10.71%8.01%0.61%
EBITDA15.77M53.76M86.47M96.57M146.02M196.99M333.02M451.10M577.15M685.59M899.30M701.26M469.28M655.88M913.35M1.13B1.05B966.42M387.29M
EBITDA Margin28.06%45.29%46.24%42.90%38.04%35.07%27.09%21.51%20.15%20.48%23.26%20.78%11.11%13.11%14.08%14.73%15.76%15.82%6.70%
Net Income7.36M39.85M64.39M80.97M102.03M122.16M231.10M339.54M447.01M534.90M658.53M450.73M210.80M402.53M573.39M687.32M624.24M506.63M21.47M
Net Income Margin13.09%33.58%34.43%35.97%26.58%21.75%18.80%16.19%15.61%15.98%17.03%13.36%4.99%8.05%8.84%8.96%9.39%8.29%0.37%
R&D------122.38M65.33M71.99M90.43M123.67M109.23M142.04M182.53M180.16M203.36M236.69M215.59M228.54M
R&D as % of Total Revenue------9.96%3.11%2.51%2.70%3.20%3.24%3.36%3.65%2.78%2.65%3.56%3.53%3.95%
Interest Expense3.29M3.47M3.33M99.21K32.92K1.17M3.17M7.02M8.18M9.58M20.42M16.93M13.83M15.27M39.95M61.50M82.18M67.43M48.57M
Interest Expense % of Total Revenue5.86%2.93%1.78%0.04%0.01%0.21%0.26%0.33%0.29%0.29%0.53%0.50%0.33%0.31%0.62%0.80%1.24%1.10%0.84%

Balance Sheet

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets105.62M175.03M217.14M1.06B1.28B1.41B1.80B2.22B3.04B6.47B7.28B7.43B7.48B8.43B10.18B11.61B12.63B11.84B11.17B
Total Liabilities84.34M113.79M91.63M134.90M182.14M357.47M415.19M516.40M684.85M1.18B1.24B919.62M907.61M1.36B2.79B3.65B4.17B2.97B2.37B
Total Equity21.28M61.13M125.51M926.88M1.01B967.77M1.38B1.69B2.35B5.27B5.93B6.35B6.41B6.79B7.19B7.77B8.29B8.71B8.64B
Cash5.05M69.69M66.12M867.20M769.88M543.05M479.25M400.51M593.64M1.39B1.37B1.35B1.21B987.97M1.13B1.32B1.21B1.57B1.31B
Total Debt46.79M47.04M18.01M2.77M-105.00M114.90M81.40M195.90M316.63M496.61M270.39M216.00M369.81M1.16B1.96B2.09B1.34B656.57M
Net Debt41.74M-22.65M-48.11M-864.43M-769.88M-438.05M-364.35M-319.11M-397.74M-1.08B-877.33M-1.08B-992.52M-618.16M33.64M648.87M884.45M-40.24M-649.62M

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow1.22M72.01M77.74M135.06M46.25M35.64M152.21M143.60M149.94M121.00M448.08M742.38M388.19M216.10M196.66M391.60M745.35M1.53B852.24M
Investing Cash Flow-29.24K-8.51M-47.19M-347.78M-312.22M-183.13M-2.88M-187.98M-154.47M-122.89M-605.64M-504.45M-309.79M-504.96M-562.04M-642.27M-728.44M-402.92M-170.26M
Financing Cash Flow-6.95M1.15M-34.12M703.80M-29.44M49.26M83.83M-63.25M221.79M841.89M117.25M-308.02M-218.43M167.09M500.31M464.80M-150.60M-768.50M-960.64M
Capital Expenditure3.12M5.87M48.28M49.82M112.90M262.51M221.17M107.20M178.37M223.35M415.52M383.34M294.89M591.01M563.78M677.45M770.27M347.12M193.12M
Free Cash Flow-1.89M66.14M29.46M85.24M-66.65M-226.87M-68.95M36.40M-28.43M-102.36M32.55M359.04M93.30M-374.91M-367.12M-285.85M-24.93M1.18B659.12M
Dividends Paid3.29M3.47M3.33M1.06M25.17M27.81M34.08M31.60M46.22M70.51M72.89M94.26M70.90M59.52M150.29M120.17M120.17M154.70M137.11M
FCF to OCF-154.50%91.84%37.90%63.11%-144.12%-636.60%-45.30%25.35%-18.96%-84.59%7.27%48.36%24.03%-173.49%-186.67%-73.00%-3.34%77.31%77.34%
Dividend Paid to FCF-174.10%5.25%11.31%1.24%-37.77%-12.26%-49.43%86.82%-162.55%-68.89%223.90%26.25%75.99%-15.88%-40.94%-42.04%-482.10%13.08%20.80%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 19, 2014Oct 23, 2014Feb 16, 2015Apr 21, 2015Aug 17, 2015Oct 26, 2015Feb 26, 2016Apr 26, 2016Aug 26, 2016Oct 24, 2016Mar 1, 2017Apr 25, 2017Aug 24, 2017Oct 30, 2017Feb 28, 2018Apr 19, 2018Aug 20, 2018Oct 29, 2018Mar 29, 2019Apr 2, 2019Aug 26, 2019Oct 28, 2019Apr 28, 2020Aug 24, 2020Oct 29, 2020Apr 27, 2021Aug 27, 2021Oct 28, 2021Feb 28, 2022Apr 28, 2022Aug 29, 2022Oct 24, 2022Mar 30, 2023Apr 27, 2023Aug 29, 2023Oct 25, 2023Mar 29, 2024Apr 25, 2024Aug 30, 2024Oct 24, 2024Mar 28, 2025Apr 27, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------0.060.050.060.060.040.040.060.03-----------------------------
EPS Actual0.010.010.010.020.010.010.020.020.020.030.030.020.020.040.030.030.030.050.040.040.030.060.070.040.040.060.050.060.040.050.060.060.060.060.04-0.080.060.060.06-0.040.080.08-0.010.080.070.020.080.040.040.050.050.060.05-0.000.020.030.01-0.050.020.010.00-0.020.020.00
Surprise---------------------------0.00%-20.00%-16.67%0.00%50.00%50.00%0.00%33.33%-----------------------------
Timing-----------------Pre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap9.76B
Enterprise Value8.47B
Trailing P/E325.00
Forward P/E51.02
PEG Ratio0.00
Price / Sales2.25
Price / Book1.14
EPS0.01
Book Value2.85
Revenue (TTM)4.33B
Gross Profit (TTM)2.56B
EBITDA445.88M
Profit Margin0.41%
Operating Margin2.98%
Return on Equity0.24%
Return on Assets1.07%
Shares Outstanding3.00B
Shares Float1.90B
Beta0.03
Dividend Yield0.31%
Dividend Rate0.01
Payout Ratio1.67%

Dividends

20261×
0.01Jul 15, 2026
20251×
0.03Jun 24, 2025
20241×
0.03May 23, 2024
20231×
0.03May 12, 2023
20221×
0.04May 19, 2022
20211×
0.04Jun 10, 2021
20201×
0.05Jun 1, 2020
20191×
0.02May 16, 2019
20181×
0.02May 18, 2018
20171×
0.03May 24, 2017
20161×
0.02May 25, 2016
20151×
0.02May 26, 2015
20141×
0.01May 19, 2014
20131×
0.01May 7, 2013
20121×
0.01May 10, 2012
20111×
0.01May 19, 2011
20101×
0.01May 10, 2010

Stock Splits

  • Oct 26, 201630:10
  • May 26, 201515:10
  • May 19, 201415:10
  • May 7, 201315:10
  • May 10, 201215:10
  • May 19, 201115:10
  • May 10, 201020:10